Compound Radar

Solventum Corporation (SOLV) Stock Analysis

Price $90.11
Market cap $15.34B
Next earnings Nov 5, 2026
Entry status Good Entry

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

53
53/100 Acceptable
  • Financial Health 40
  • Profitability 50
  • Business Quality 75
  • Balance Sheet 40
  • Cash Flow 50

Why this rating?

Health 53/100 — Acceptable

Strongest Business Quality 75/100
Softest Balance Sheet 40/100
Good Entry

A usable setup — not as clean as Strong Entry, but timing is not mixed or weak.

Company overview

Solventum Corporation (SOLV) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Solventum Corporation 53/100 (Acceptable) due to high business quality, steady revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 11.02
  • Forward P/E 12.47
  • PEG 1.22
  • EV/Revenue 2.47

Profitability

  • Revenue Growth 2.2%
  • Gross Margin 54.8%
  • Operating Margin 9.8%
  • Net Margin 17.3%
  • ROE 34.0%

Financial strength

  • Cash $403.00M
  • Debt $5.30B
  • Net Cash $-4.89B
  • Free Cash Flow $-10.00M
  • Current Ratio 1.02

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Solventum Corporation (SOLV).

View Methodology & FAQ →